S.Korea in talks with mRNA vaccine makers to make up to one billion doses, says govt official

S.Korea in talks with mRNA vaccine makers to make up to one billion doses, says govt official
S.Korea in talks with mRNA vaccine makers to make up to one billion doses, says govt official

Hello and welcome to the details of S.Korea in talks with mRNA vaccine makers to make up to one billion doses, says govt official and now with the details

Nevin Al Sukari - Sana'a - South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce Covid-19 shots in the country. — Reuters pic

SEOUL, July 5 — South Korea is in talks with mRNA vaccine makers including Pfizer and Moderna to produce Covid-19 shots in the country and is ready to offer the capacity to make up to one billion doses immediately, a senior government official said.

The plan, if agreed, would help ease tight global supply of Covid-19 vaccines, particularly in Asia which lags North America and Europe in vaccine rollouts, and put South Korea a step closer to its ambition to become a major vaccine manufacturing centre.

South Korea already has deals to locally produce three coronavirus vaccines developed by AstraZeneca/Oxford University, Novavax, and Russia. It also has a vaccine bottling and packaging deal with Moderna.

“We’ve been holding frequent talks with big pharmaceutical companies to produce mRNA vaccines,” Lee Kang-ho, director general for the global vaccine hub committee under South Korea’s health ministry, told Reuters in an interview.

“There are only a few mRNA vaccine developers — Pfizer, Moderna, CureVac and BioNTech. Thus there’s a limit to how much they can produce to meet global demand... South Korea is keen to help by offering its facilities and skilled human resources,” Lee said.

It’s not immediately clear how advanced these talks are and whether and when a deal will be agreed.

BioNTech declined to comment, Moderna and CureVac did not reply to Reuters’ requests for comments.

A Pfizer spokesperson said the company is making efforts to enhance its Covid-19 vaccine supply chain but added “we do not have anything specific to announce at this time.”

Lee declined to name local vaccine makers which have the capacity to produce mRNA vaccines immediately, but a government source said they include Hanmi Pharmaceuticals Co Ltd and Quratis Co Ltd.

Hanmi confirmed that it has a big capacity reserved for Sanofi’s diabetes drug and it can be used for Covid-19 vaccine production as the Sanofi project has stalled.

Quratis, which makes a tuberculosis vaccine, said its new factory built last year can now be used for mRNA vaccine production. — Reuters

These were the details of the news S.Korea in talks with mRNA vaccine makers to make up to one billion doses, says govt official for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT Fully vaccinated expats can return to Kuwait as of Sunday